American journal of hypertension · 2026
Clinician Fidelity with Hypertension Quality Improvement Program is Associated with Blood Pressure Control within a Clinician-Patient Panel.
СтатьяПоддержка исследования: вне правительства СШАПоддержка NIH: внешняя программаНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dimond Matthew, Markossian Talar W, Probst Beatrice D, Habicht Katherine, Kramer Holly J
Аннотация
BACKGROUND: Differences in clinician fidelity with hypertension quality improvement (QI) interventions may influence blood pressure (BP) control.
METHODS: This analysis included data from 35,115 patients with 89,230 clinical encounters during a calendar year conducted by 87 physicians, 7 advanced practice nurses, and 173 residents to examine the association of fidelity measures with QI interventions and BP control for a clinician-patient panel. BP control (BP < 140/90 mm Hg) was based on vital signs at last clinic visit. The QI program fidelity measures included (1) documented automated office BP (AOBP) to confirm initial elevated BP, (2) 30-day follow-up visits when clinic BP is uncontrolled, (3) appropriate escalation of medications during visits with uncontrolled BP, and (4) use of combination BP-lowering medications. Linear mixed-effects models were used to examine the association of QI program fidelity measure quartiles with patient panel BP control, while adjusting for patient panel characteristics.
RESULTS: The mean patient age was 63.2 years (SD 12.8), 45.1% were men; race/ethnicity was Non-Hispanic (NH) White in 60.5%, NH Black in 20.3%, and Hispanic in 14.0%. Average patient panel BP control rate was 69.1%. After adjustment, the highest AOBP and 30-day follow-up visit quartiles were associated with a 15.1% (95% CI, 8.9%-21.4%) and 12.3% (95% CI, 6.8%-17.7%) higher percentage of clinician-patient panels with controlled BP compared to the lowest quartile. No association was noted with other fidelity measures and BP control.
CONCLUSION: Increasing fidelity with hypertension QI interventions may help clinicians improve BP control rates within their patient panel.
METHODS: This analysis included data from 35,115 patients with 89,230 clinical encounters during a calendar year conducted by 87 physicians, 7 advanced practice nurses, and 173 residents to examine the association of fidelity measures with QI interventions and BP control for a clinician-patient panel. BP control (BP < 140/90 mm Hg) was based on vital signs at last clinic visit. The QI program fidelity measures included (1) documented automated office BP (AOBP) to confirm initial elevated BP, (2) 30-day follow-up visits when clinic BP is uncontrolled, (3) appropriate escalation of medications during visits with uncontrolled BP, and (4) use of combination BP-lowering medications. Linear mixed-effects models were used to examine the association of QI program fidelity measure quartiles with patient panel BP control, while adjusting for patient panel characteristics.
RESULTS: The mean patient age was 63.2 years (SD 12.8), 45.1% were men; race/ethnicity was Non-Hispanic (NH) White in 60.5%, NH Black in 20.3%, and Hispanic in 14.0%. Average patient panel BP control rate was 69.1%. After adjustment, the highest AOBP and 30-day follow-up visit quartiles were associated with a 15.1% (95% CI, 8.9%-21.4%) and 12.3% (95% CI, 6.8%-17.7%) higher percentage of clinician-patient panels with controlled BP compared to the lowest quartile. No association was noted with other fidelity measures and BP control.
CONCLUSION: Increasing fidelity with hypertension QI interventions may help clinicians improve BP control rates within their patient panel.